ISG15 and neoplasm: ISG15 expressing TAMs impaired antitumor CTL response according to effector production by the digested live cells from tumor samples and in vitro activated CD8+ cells treated with ISG15-treated macrophages, suggesting ISG15-treated macrophages may contribute to malignant transformation through suppressive regulation on CTL response to tumor.